Citigroup’s Celgene Corp CELG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | – | Sell |
-267,800
| Closed | -$26.6M | – | 8000 |
|
|
2019
Q3 | $26.6M | Sell |
267,800
-82,400
| -24% | -$7.83M | 0.02% | 768 |
|
|
2019
Q2 | $32.4M | Sell |
350,200
-1,439,600
| -80% | -$137M | 0.03% | 645 |
|
|
2019
Q1 | $169M | Buy |
1,789,800
+1,284,100
| +254% | +$112M | 0.16% | 105 |
|
|
2018
Q4 | $32.4M | Sell |
505,700
-56,900
| -10% | -$4.2M | 0.03% | 579 |
|
|
2018
Q3 | $50.3M | Sell |
562,600
-222,600
| -28% | -$19.7M | 0.04% | 386 |
|
|
2018
Q2 | $62.4M | Buy |
785,200
+85,000
| +12% | +$7.06M | 0.06% | 290 |
|
|
2018
Q1 | $62.5M | Sell |
700,200
-13,200
| -2% | -$1.27M | 0.05% | 324 |
|
|
2017
Q4 | $74.5M | Buy |
713,400
+72,700
| +11% | +$8.2M | 0.06% | 297 |
|
|
2017
Q3 | $93.4M | Buy |
640,700
+31,900
| +5% | +$4.35M | 0.08% | 214 |
|
|
2017
Q2 | $79.1M | Sell |
608,800
-34,500
| -5% | -$4.23M | 0.07% | 218 |
|
|
2017
Q1 | $80M | Buy |
643,300
+195,900
| +44% | +$23.4M | 0.07% | 234 |
|
|
2016
Q4 | $51.8M | Buy |
447,400
+10,900
| +2% | +$1.21M | 0.05% | 377 |
|
|
2016
Q3 | $45.6M | Buy |
436,500
+107,800
| +33% | +$11.7M | 0.04% | 366 |
|
|
2016
Q2 | $32.4M | Sell |
328,700
-20,700
| -6% | -$2.14M | 0.03% | 451 |
|
|
2016
Q1 | $35M | Sell |
349,400
-182,600
| -34% | -$18.8M | 0.04% | 401 |
|
|
2015
Q4 | $63.7M | Buy |
532,000
+14,100
| +3% | +$1.63M | 0.06% | 285 |
|
|
2015
Q3 | $56M | Sell |
517,900
-8,600
| -2% | -$1.07M | 0.05% | 317 |
|
|
2015
Q2 | $60.9M | Sell |
526,500
-21,400
| -4% | -$2.45M | 0.05% | 329 |
|
|
2015
Q1 | $63.2M | Sell |
547,900
-241,600
| -31% | -$28.9M | 0.06% | 292 |
|
|
2014
Q4 | $88.3M | Buy |
789,500
+94,600
| +14% | +$9.98M | 0.08% | 241 |
|
|
2014
Q3 | $65.9M | Buy |
694,900
+104,000
| +18% | +$9.39M | 0.06% | 311 |
|
|
2014
Q2 | $50.7M | Buy |
590,900
+17,100
| +3% | +$1.3M | 0.05% | 354 |
|
|
2014
Q1 | $40.1M | Sell |
573,800
-282,200
| -33% | -$22.3M | 0.04% | 401 |
|
|
2013
Q4 | $72.3M | Buy |
856,000
+204,200
| +31% | +$16.2M | 0.07% | 276 |
|
|
2013
Q3 | $50.2M | Buy |
651,800
+153,000
| +31% | +$10.7M | 0.05% | 346 |
|
|
2013
Q2 | $29.2M | Buy |
+498,800
| New | +$30M | 0.03% | 506 |
|
Other funds holding CELG
FP
HCM
PCMC
WCG
Citigroup's CELG Position: Q4 2019 in Review
Citigroup sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 7,545,707 shares — an estimated $749M sold.
Citigroup first reported a position in CELG in Q2 2013 and held it in 26 quarters. The position peaked at $749M in Q3 2019. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.
- Citigroup reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
- Citigroup sold 7,545,707 Celgene Corp shares in Q4 2019, an estimated $749M.
- Citigroup first reported a position in Celgene Corp in Q2 2013 and held it in 26 quarters.
- Citigroup's Celgene Corp position peaked at $749M in Q3 2019.
- 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.
Based on Citigroup's 13F filing for Q4 2019, filed 12 Feb 2020.